U.S. markets close in 5 hours 14 minutes
  • S&P 500

    4,180.74
    +35.55 (+0.86%)
     
  • Dow 30

    33,076.93
    +273.46 (+0.83%)
     
  • Nasdaq

    12,814.77
    +157.22 (+1.24%)
     
  • Russell 2000

    1,953.19
    +31.36 (+1.63%)
     
  • Crude Oil

    88.59
    -0.42 (-0.47%)
     
  • Gold

    1,805.20
    +14.00 (+0.78%)
     
  • Silver

    20.63
    +0.79 (+3.97%)
     
  • EUR/USD

    1.0211
    +0.0024 (+0.23%)
     
  • 10-Yr Bond

    2.7720
    -0.0680 (-2.39%)
     
  • GBP/USD

    1.2122
    +0.0051 (+0.42%)
     
  • USD/JPY

    134.6310
    -0.3390 (-0.25%)
     
  • BTC-USD

    24,153.05
    +1,027.48 (+4.44%)
     
  • CMC Crypto 200

    563.86
    +20.98 (+3.87%)
     
  • FTSE 100

    7,500.20
    +60.46 (+0.81%)
     
  • Nikkei 225

    28,249.24
    +73.37 (+0.26%)
     

Olink to present at two upcoming investor conferences

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

UPPSALA, Sweden, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Jon Heimer, CEO, and Oskar Hjelm, CFO, will participate in the following virtual investor conferences:

  • Goldman Sachs Eighteenth Annual European Medtech and Healthcare Services Conference
    Fireside chat on Wednesday, September 8th at 10:30 a.m. ET

  • Morgan Stanley 19th Annual Global Healthcare Conference
    Fireside chat on Friday, September 10th at 8:00 a.m. ET

Live and archived webcasts of the events will be available on the “Investors” section of the Company’s website at https://investors.olink.com/investor-relations.

About Olink Holding

Olink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The company was founded in 2016 and is well established across Europe, North America and Asia. Olink is headquartered in Uppsala, Sweden.

Contacts
Media and Investor Relations
Olink Holding AB (publ), Stina Thorman, stina.thorman@olink.com, +46707187354